Cory Ellspermann
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Cory Ellspermann is Senior Manager-Accounting at Artivest Holdings, Inc. since 2017.
Mr. Ellspermann is Chief Financial Officer at INmune Bio, Inc. starting in 2025.
Formerly, Mr. Ellspermann was Chief Accounting Officer at iDirect Private Markets Fund.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INMUNE BIO, INC. -.--% | 20/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INMUNE BIO INC. | Directeur Financier/CFO | 07/08/2025 |
Artivest Holdings, Inc.
Artivest Holdings, Inc. Financial ConglomeratesFinance Provides investment services | Comptroller/Controller/Auditor | 01/01/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| ALTEGRIS KKR COMMITMENTS FUND | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
iDirect Private Markets Fund
iDirect Private Markets Fund Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Artivest Holdings, Inc.
Artivest Holdings, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
INmune Bio, Inc.
INmune Bio, Inc. BiotechnologyHealth Technology Develops therapies that harness the patient's immune system to treat cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national